Author:
Heimberger Amy B.,Sun Wei,Hussain S. Farzana,Dey Mahua,Crutcher Lamonne,Aldape Ken,Gilbert Mark,Hassenbusch Samuel J.,Sawaya Raymond,Schmittling Bob,Archer Gary E.,Mitchell Duane A.,Bigner Darell D.,Sampson John H.
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Clinical Neurology,Oncology
Reference26 articles.
1. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352: 987-996.
2. Liau LM, Prins RM, Kiertscher SM, et al. Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Clin Cancer Res. 2005;11: 5515-5525.
3. Archer G, Bigner D, Friedman A, et al. Dendritic cell vaccine for intracranial tumors I (DC Victori Trial). Paper presented at: Society for Neuro-Oncology, Education Day and Ninth Annual Scientific Meeting; 2004;Toronto, Ontario, Canada.
4. Su YB, Sohn S, Krown SE, et al. Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. J Clin Oncol. 2004;22: 610-616.
5. Heimberger AB, Archer GE, Crotty LE, et al. Dendritic cells pulsed with a tumor-specific peptide induce long-lasting immunity and are effective against murine intracerebral melanoma. Neurosurgery. 2002;50: 158-164.
Cited by
104 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献